Management of Patients Undergoing Coronary Artery
... Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery; TIMI, Thrombolysis In Myocardial Infarction; UA/ NSTEMI, unstable angina/non-ST-elevation myocardial infarction; and UPLM, unprotected left main disease. ...
... Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery; TIMI, Thrombolysis In Myocardial Infarction; UA/ NSTEMI, unstable angina/non-ST-elevation myocardial infarction; and UPLM, unprotected left main disease. ...
Influence of pneumoperitoneum on left ventricular filling pressures
... as a surrogate in estimation of LV filling pressures. It is widely accepted the relationship between the concentration of this hormone and structural and functional cardiac diseases. Several Authors described the hemodynamic effects of the Pnp created for laparoscopic surgery. Increases in heart rat ...
... as a surrogate in estimation of LV filling pressures. It is widely accepted the relationship between the concentration of this hormone and structural and functional cardiac diseases. Several Authors described the hemodynamic effects of the Pnp created for laparoscopic surgery. Increases in heart rat ...
pdf Living with an ICD
... disorders or who are at significant risk of developing heart rhythm disorders. An ICD is placed inside your body and works automatically. Risks associated with an ICD system implant include, but are not limited to, infection at the surgical site and/or sensitivity to the device material, failure to ...
... disorders or who are at significant risk of developing heart rhythm disorders. An ICD is placed inside your body and works automatically. Risks associated with an ICD system implant include, but are not limited to, infection at the surgical site and/or sensitivity to the device material, failure to ...
Acute hyperglycaemia: a `new` risk factor during myocardial infarction
... in the use of insulin following acute MI.54 It first reported on the feasibility of the use of an insulin–glucose infusion following MI in patients with a plasma glucose level of 11 mmol/L;54 a later paper reported the 1 year mortality and morbidity results.55 The final paper published in May 1999 re ...
... in the use of insulin following acute MI.54 It first reported on the feasibility of the use of an insulin–glucose infusion following MI in patients with a plasma glucose level of 11 mmol/L;54 a later paper reported the 1 year mortality and morbidity results.55 The final paper published in May 1999 re ...
Review Article - Departamentos e GEs
... Figure 1 shows the PET images with 18F-FDG in patients with previous diagnosis of cardiac sarcoidosis who had worsening of cardiac function, raising suspicions of disease reactivation. Heterogeneous radiotracer uptake in the left ventricle, even after physiological uptake suppression protocol, confi ...
... Figure 1 shows the PET images with 18F-FDG in patients with previous diagnosis of cardiac sarcoidosis who had worsening of cardiac function, raising suspicions of disease reactivation. Heterogeneous radiotracer uptake in the left ventricle, even after physiological uptake suppression protocol, confi ...
life with an implantable defibrillator
... disorders or who are at significant risk of developing heart rhythm disorders. An ICD is placed inside your body and works automatically. Risks associated with an ICD system implant include, but are not limited to, infection at the surgical site and/or sensitivity to the device material, failure to ...
... disorders or who are at significant risk of developing heart rhythm disorders. An ICD is placed inside your body and works automatically. Risks associated with an ICD system implant include, but are not limited to, infection at the surgical site and/or sensitivity to the device material, failure to ...
Effects of the Anticholinesterase Edrophonium on Spectral Analysis
... ters. After this interval, a 20 gauge catheter was inserted into a radial arterial to record systemic arterial pressure if heart rate was above 55 beats 䡠 min⫺1 (three patients were excluded for low heart rates). Continuous ECG (lead II), systemic arterial blood pressure, and ventilation pressure we ...
... ters. After this interval, a 20 gauge catheter was inserted into a radial arterial to record systemic arterial pressure if heart rate was above 55 beats 䡠 min⫺1 (three patients were excluded for low heart rates). Continuous ECG (lead II), systemic arterial blood pressure, and ventilation pressure we ...
Management of Patients Undergoing Coronary Artery
... Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery; TIMI, Thrombolysis In Myocardial Infarction; UA/ NSTEMI, unstable angina/non-ST-elevation myocardial infarction; and UPLM, unprotected left main disease. ...
... Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery; TIMI, Thrombolysis In Myocardial Infarction; UA/ NSTEMI, unstable angina/non-ST-elevation myocardial infarction; and UPLM, unprotected left main disease. ...
EECP - SuperCoder
... and congestive heart failure. It uses timed, sequential inflation of pressure cuffs on the calves, thighs, and buttocks to augment diastolic pressure, decrease left ventricular afterload, and increase venous return. Augmenting diastolic pressure displaces a volume of blood backward into the coronary ...
... and congestive heart failure. It uses timed, sequential inflation of pressure cuffs on the calves, thighs, and buttocks to augment diastolic pressure, decrease left ventricular afterload, and increase venous return. Augmenting diastolic pressure displaces a volume of blood backward into the coronary ...
Heart Disease - Scottish Intercollegiate Guidelines Network
... D Temporary transcutaneous pacing should be initiated quickly in patients not responding to atropine. D When atropine or transcutaneous pacing is ineffective consider adrenaline/epinephrine, dopamine, isoprenaline or aminophylline infusions before transvenous pacing is instituted. Transcutane ...
... D Temporary transcutaneous pacing should be initiated quickly in patients not responding to atropine. D When atropine or transcutaneous pacing is ineffective consider adrenaline/epinephrine, dopamine, isoprenaline or aminophylline infusions before transvenous pacing is instituted. Transcutane ...
Craniofacial Pain of Cardiac Origin Is Associated
... shoulders.10 These findings were reinforced by the present results, now based on a larger population of patients. In addition, it was found that this frequency of pain referral to the craniofacial area also occurred in preinfarction angina. In the present study, the prevalence of AMI presentation wi ...
... shoulders.10 These findings were reinforced by the present results, now based on a larger population of patients. In addition, it was found that this frequency of pain referral to the craniofacial area also occurred in preinfarction angina. In the present study, the prevalence of AMI presentation wi ...
Predicative value of preoperative C
... as described by previous studies [17], preoperative RCRI evaluation did not predict postoperative adverse cardiac events in our present study supported by the results of multiple logistic regression analysis. The discrepancy may ascribe to the differences in the sample size, inclusion and exclusion ...
... as described by previous studies [17], preoperative RCRI evaluation did not predict postoperative adverse cardiac events in our present study supported by the results of multiple logistic regression analysis. The discrepancy may ascribe to the differences in the sample size, inclusion and exclusion ...
Co-prevalence of Carotid Stenosis with Coronary Artery Disease in
... Western habit in Chinese population. In 261 consecutive patients with AF, Kralev et al.8 repoeted that the prevalence of CAD was 34% in the overall patients and 41% in patients >70 years; notably, 21% of patients underwent a percutaneous coronary intervention (PCI) or coronary artery bypass graft ( ...
... Western habit in Chinese population. In 261 consecutive patients with AF, Kralev et al.8 repoeted that the prevalence of CAD was 34% in the overall patients and 41% in patients >70 years; notably, 21% of patients underwent a percutaneous coronary intervention (PCI) or coronary artery bypass graft ( ...
Reduce Your Risk of Stroke Starting Now
... More on Women and Stroke Characteristics that are specific to women, such as use of birth control pills and post-menopausal hormone therapy, can increase stroke risk. Also, many of the first signs of vascular disease that can lead to stroke are often revealed during pregnancy. Stroke risk is increa ...
... More on Women and Stroke Characteristics that are specific to women, such as use of birth control pills and post-menopausal hormone therapy, can increase stroke risk. Also, many of the first signs of vascular disease that can lead to stroke are often revealed during pregnancy. Stroke risk is increa ...
Acetyl salicylic acid resistance in patients with chronic stable angina
... salicylic acid resistance was noted in 5.2%. Multivariate analysis demonstrated that, in addition to other risk factors, ASA resistance was an independent predictor of adverse outcomes.17 Chen et al18 found that patients with elective percutaneous coronary intervention (PCI) who take ASA had ASA res ...
... salicylic acid resistance was noted in 5.2%. Multivariate analysis demonstrated that, in addition to other risk factors, ASA resistance was an independent predictor of adverse outcomes.17 Chen et al18 found that patients with elective percutaneous coronary intervention (PCI) who take ASA had ASA res ...
CRITICAL ILLNESS - Impact Trade Union
... We do not cover cancers ‘in situ’ (cancers in a very early stage that have not spread in any way to neighbouring tissue) or premalignant and non-invasive tumours. These are well-recognised conditions, and cancers detected at this stage are not likely to be lifethreatening and are usually easily trea ...
... We do not cover cancers ‘in situ’ (cancers in a very early stage that have not spread in any way to neighbouring tissue) or premalignant and non-invasive tumours. These are well-recognised conditions, and cancers detected at this stage are not likely to be lifethreatening and are usually easily trea ...
RESPeRATE- Nonpharmacological Treatment of Hypertension
... espite many recent advances in the medical treatment of systemic hypertension and the public health campaigns aimed at reducing its incidence, hypertension remains a significant worldwide public health problem. Hypertension increases the risk of coronary artery disease, congestive heart failure (CHF ...
... espite many recent advances in the medical treatment of systemic hypertension and the public health campaigns aimed at reducing its incidence, hypertension remains a significant worldwide public health problem. Hypertension increases the risk of coronary artery disease, congestive heart failure (CHF ...
QT interval dispersion in obstructive sleep apnoea syndrome patients without hypertension
... precursor of arrhythmias. Obstructive sleep apnoea syndrome (OSAS) can cause cardiovascular complications, such as arrhythmias, myocardial infarction, and systemic and pulmonary hypertension. The aim of this study was to assess QTd in OSAS patients without hypertension. A total of 49 subjects withou ...
... precursor of arrhythmias. Obstructive sleep apnoea syndrome (OSAS) can cause cardiovascular complications, such as arrhythmias, myocardial infarction, and systemic and pulmonary hypertension. The aim of this study was to assess QTd in OSAS patients without hypertension. A total of 49 subjects withou ...
in Congestive Heart Failure
... beneficially even in cardiac dysfunction with lowered blood pressure by adding dopamine. In the present study it was considered that the positive inotropic agent, dopamine, infused concomitantly with nitroprusside, which reduces afterload, could enhance pump function to a degree unattainable with ei ...
... beneficially even in cardiac dysfunction with lowered blood pressure by adding dopamine. In the present study it was considered that the positive inotropic agent, dopamine, infused concomitantly with nitroprusside, which reduces afterload, could enhance pump function to a degree unattainable with ei ...
Roles of Nuclear Cardiology, Cardiac Computed Tomography, and
... survival superior to that of patients referred for revascularization. On the other hand, when moderate-to-severe ischemia (.10% of the total myocardium ischemic) was detected by MPS, patients undergoing revascularization have shown an increased survival benefit over patients undergoing medical thera ...
... survival superior to that of patients referred for revascularization. On the other hand, when moderate-to-severe ischemia (.10% of the total myocardium ischemic) was detected by MPS, patients undergoing revascularization have shown an increased survival benefit over patients undergoing medical thera ...
Expiratory flow limitation as a determinant of orthopnea in
... the sitting position. Follow-up studies were conducted in two patients several days later to examine the effects of treatment. Changes in functional residual capacity between the sitting and the supine position were assessed by comparing the corresponding inspiratory capacities. This was carried out ...
... the sitting position. Follow-up studies were conducted in two patients several days later to examine the effects of treatment. Changes in functional residual capacity between the sitting and the supine position were assessed by comparing the corresponding inspiratory capacities. This was carried out ...
Clinical excellence in computerized ECG analysis GE Healthcare
... As compared to thrombolytic therapy, primary PTCA has been shown to lower cost51 and shorten length-of-hospital-stay.52 However, expediting patients through the emergency medical system (EMS) to a prepared cath lab takes more planning and is more complex.53 As more community hospitals adopt this new ...
... As compared to thrombolytic therapy, primary PTCA has been shown to lower cost51 and shorten length-of-hospital-stay.52 However, expediting patients through the emergency medical system (EMS) to a prepared cath lab takes more planning and is more complex.53 As more community hospitals adopt this new ...
Anastomosis in Pulmonary Atresia with Intact Ventricular Septum
... In our case, stent placement was done into the patent ductus arteriosus at 3 months of age and she had a successful BDG shunt operation four months later. The patent ductus arteriosus stent implantation in patients with cyanotic congenital heart disease and duct-dependent pulmonary blood flow is tec ...
... In our case, stent placement was done into the patent ductus arteriosus at 3 months of age and she had a successful BDG shunt operation four months later. The patent ductus arteriosus stent implantation in patients with cyanotic congenital heart disease and duct-dependent pulmonary blood flow is tec ...
ÖGARI Task Force „Preoperative Evaluation“ Guideline for
... on the type of stent (platelet aggregation inhibitors) it is advisable not to perform any operation up to 1 year! c) Special Risk • Valvular heart disease ∗ Aortic valve stenosis is another considerable risk factor for perioperative complications. There is an independent relative risk (RR) of 5.2 wi ...
... on the type of stent (platelet aggregation inhibitors) it is advisable not to perform any operation up to 1 year! c) Special Risk • Valvular heart disease ∗ Aortic valve stenosis is another considerable risk factor for perioperative complications. There is an independent relative risk (RR) of 5.2 wi ...
Stroke prevention strategies in patients with atrial fibrillation and
... Given that all four NOACs have been approved for stroke prevention in patients with non-valvular AF, the diagnosis of valvular AF would exclude the option of NOAC use for stroke prevention in such patient. Indeed, NOACs are not recommended for stroke prevention in AF patients with mechanical prosthe ...
... Given that all four NOACs have been approved for stroke prevention in patients with non-valvular AF, the diagnosis of valvular AF would exclude the option of NOAC use for stroke prevention in such patient. Indeed, NOACs are not recommended for stroke prevention in AF patients with mechanical prosthe ...